share_log
Moomoo 24/7 ·  Apr 17 08:06
Psyence Biomedical Ltd: Anticipates Enrolling First Subject in Q2 of 2024 and Expects Primary Endpoint Results to Be Available in 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment